About Us
Articles & Insights
Press Releases
Contact Us
Market Research to
Gain the Competitive Edge
Customer Loyalty
Designed to help our clients attract and retain loyal customers, the High Tech Business Decisions Customer Loyalty Program includes assessments of customer satisfaction and loyalty, performance ratings and comparisons to competitors, and discernment of current customers' future plans.
Industry Insights
The following directories of leading edge suppliers are provided as a courtesy.

"With expertise in complex pharmaceutical drug discovery, biomanufacturing, and electronics manufacturing technologies, our highly trained analysts investigate markets for high tech business-to-business products and services. Our custom reports are in-depth analyses that bring leading edge science together with profitable business strategies for the pharmaceutical and electronics industries."  William P. Downey, President

New Report Just Published

Biopharmaceutical Contract Fill-and-Finish: Best Practices Study 2018

This 650-page report, the comprehensive 2018 industry study, provides the latest information on current and future market size, manufacturing technologies and practices, client outsourcing plans, contract outsource capacity, pricing, commercial terms and practices, underserved market needs, and future industry trends in the fill-and-finish contract manufacturing industry. This report highlights both the growth opportunities and challenges facing the contract fill-and-finish industry with respect to aseptic fill. The data and the analysis in this report are based on 38 in-depth interviews with biomanufacturing directors at pharmaceutical and biotechnology companies, and executives from fill-and-finish contract manufacturing organizations worldwide. This report also contains detailed company profiles from 60 fill-and-finish contract manufacturing organizations worldwide, covering information on type of services offered to help with preliminary fill-and-finish CMO research. The analysis of these perspectives provides the readers with insights to understand current and future trends in the biopharmaceutical contract fill-and-finish market, and it equips one with tool to make strategic decisions. This report includes over 175 summary data tables and charts, and is the most comprehensive and current industry report on biopharmaceutical fill-and-finish contract manufacturing. Published January 2018.

Directory of Biopharmaceutical Fill-and-Finish Contract Manufacturers

The 2018 directory provides a thorough listing of 60 biopharmaceutical fill-and-finish contract manufacturers worldwide, including information on type of services offered, equipment capacity, cGMP certification by service category and more.

Published Reports

Biopharmaceutical Contract Manufacturing 2017:
Growing Markets, Capacities, and Innovations

This 900-page report provides the latest information about the supply and demand for the outsource production of large-molecule drug substance. This report analyzes the biotechnology industry’s biomanufacturing strategies, budgets, contractor relationships and new projects. This report also provides detailed analyses of typical batch sizes and product requirements by major production technology for both clinical and commercial production. In addition, this report highlights CMO capacity, current and projected utilization rates, and the use of proprietary expression systems. The data and the analysis in this report are based on 64 in-depth interviews conducted by Ph.D.-level analysts with both executives at biopharmaceutical and contractor companies worldwide. The analyses of their perspectives and insights allow readers to gain an understanding of the market and its future direction. This report includes over 250 summary data tables and charts, and is the most comprehensive and current industry report on biopharmaceutical contract manufacturing.

Directory of Biopharmaceutical Contract Manufacturers

The 2017 directory provides a thorough listing of 78 contractors worldwide, including service offerings, equipment, capacity, cGMP status, and other important details.

Biopharmaceutical Contract Manufacturing:
Best Practices Pricing Study 2016

This 350-page report details both the prices paid by biotechnology companies and prices charged by biopharmaceutical contract manufacturing organizations for large-molecule drug substance production. In addition, this report documents current prices for related services offered by the contract manufacturing organizations, including cell banking, cell-line development, process development, technology transfer, and regulatory support. Included in the study are contract agreements covering expectations and preferences to help set negotiation strategy as well as factors related to contractor selection such as importance of price, impact of CMO location, technology and regulatory support sought from CMO. This report provides the reader with over 225 detailed charts and tables covering industry trends, selected contract terms and prices. Prices are reported for both mammalian cell culture and microbial fermentation technologies at specific bioreactor tank sizes. In addition to production prices, this report also documents FTE rates paid and charged by major functional areas. Published August 2016.

Biopharmaceutical Mammalian Cell Culture Media Market 2014

This 180-page report provides analysis of the mammalian cell culture media market for biopharmaceutical production. The findings in this report are based on in-depth interviews with 24 scientists and manufacturing directors at pharmaceutical and biotechnology companies who are responsible for the development and production of biopharmaceuticals using mammalian cell culture. The respondents’ organizations account for one-third of the worldwide mammalian cell culture capacity. This report documents current practices regarding mammalian cell culture media used in the production of biopharmaceuticals. Topics in this report include types of media used, market forecast by segment and world area, prices paid, recent price changes, current media usage rates, opinions about suppliers, preferred suppliers, important criteria for evaluating suppliers and media, and suggestions for product and service improvements. This report provides the reader with near-verbatim inputs from the study respondents and more than 60 charts, graphs and tables. Published March 2014.

High Throughput Screening 2012: Improved Strategies, Adaptive Technologies and Enhanced Assays

This 850-page report, with over 270 charts and tables, documents the current and future role of HTS in drug discovery activities. The data and analysis contained in this report comes from extensive discussions with both HTS laboratory directors and HTS industry suppliers who were interviewed by our Ph.D.-level analysts. This report provides in-depth analysis of current HTS laboratory practices and budgets at drug innovator companies, academic and government research centers, and contract research organizations. This report documents the current and future use of high content screening, detection technologies, automation equipment, reagents, cell lines, and various targets and target classes. In addition, this report details the number of compounds screened, the level of screening activity, the use of various microplate formats, and the unmet needs of the HTS laboratory directors. Also in included in this report is a comprehensive examination of current and future spending by major product categories and by HTS laboratory segments. Published July 2012

The History of High Throughput Screening for Drug Discovery:

HighTech Business Decisions (HTBD) has conducted six market research studies and published six comprehensive industry reports on high throughput screening (HTS) since 1998. This report is specifically designed to understand the changes that have occurred in HTS since 1998, how accurate HTS directors have been in forecasting and predicting their use of technology and future needs, how HTS practices have evolved, and the success of HTS as a drug discovery tool. Topics include the number of disease targets screened, target types, assay types, detection modes, microplate formats, outsourcing, and other issues impacting HTS operations and success. The complete analysis, based on both user and supplier primary research, includes market size and growth, major players, user strategies and requirements, documentation of success in drug discovery, trends and technologies, and respondents’ perceptions regarding the future of HTS.